Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

SUMM.L (SUMM) Share News

1234

Summit Therapeutics Completes Dosing For PhaseOut Clinical Trial

19th Apr 2018 15:07

LONDON (Alliance News) - Summit Therapeutics PLC said on Thursday it has completed the ezutromid dosing of patients with Duchenne muscular dystrophy for the full 48-week PhaseOut DMD clinical was Read More

Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director

4th Apr 2018 12:53

LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopoldo Zambeletti has joined Read More

Summit Therapeutics To Raise GBP15 Million Via Share Placing (ALLISS)

27th Mar 2018 12:18

LONDON (Alliance News) - Summit Therapeutics PLC said Tuesday that it intends to raise gross proceeds of up to GBP15.0 million via share placing.The to a Read More

Summit Therapeutics Reports Progress On PhaseOut DMD Trial

14th Mar 2018 17:52

LONDON (Alliance News) - Summit Therapeutics PLC at the clinical conference in Arlington highlighted the rigour in the data collection in analysis for its PhaseOut Duchenne 2 Read More

Summit Therapeutics Details Phase III Programme For Ridinilazole

1st Feb 2017 12:15

Read More

Summit Therapeutics Appoints David Roblin As Chief Operating Officer

18th Jan 2017 12:09

Read More

Summit Therapeutics Sees Positive Phase I Trial Results For Ezutromid

9th Aug 2016 11:51

Read More

Summit Therapeutics Shows Further Positive Trial Data For Ridinilazole

21st Jun 2016 06:46

Read More

Summit Therapeutics Enrols First Patient In Phase II Ezutromid Trial

17th Jun 2016 11:21

Read More

Summit Therapeutics Posts Widened Loss As It Progresses Programmes

10th May 2016 11:20

Read More

Summit Therapeutics Gets Further US Patent For Antibiotic Ridinlazole

28th Apr 2016 11:11

Read More

Summit Therapeutics Gets Clearance To Expand Ezutromid Trial To US

26th Apr 2016 11:16

Read More

Summit Therapeutics Gets Positive Interim SMT C1100 Test Results

30th Mar 2016 11:06

Read More

Summit Therapeutics Sees Further Positive Data For Ridinilazole

7th Mar 2016 12:43

Read More

Summit Therapeutics Gets European Patent For Antibiotic Ridinilazole

19th Jan 2016 12:18

Read More

Port Erin Biopharma Continues To Look For Investments, Swings To Loss

22nd Dec 2015 12:02

Read More

Summit Therapeutics Third Quarter Loss Widens As Pipeline Progresses

17th Dec 2015 12:28

Read More

Summit Therapeutics Extends Alliance With University Of Oxford

17th Nov 2015 12:17

Read More

Summit Therapeutics To Present Positive SMT19969 Data In San Diego

18th Sep 2015 12:50

Read More

Summit Therapeutics Finishes Enrolment For Phase II SMT19969 Trial

10th Sep 2015 11:11

Read More

1234
FTSE 100 Latest
Value10,559.58
Change-49.48